Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marker Therapeutics (MRKR) Non-Current Deferred Tax Liability (2019)

Marker Therapeutics (MRKR) has disclosed Non-Current Deferred Tax Liability for 1 consecutive years, with $106000.0 as the latest value for Q4 2019.

  • Quarterly Non-Current Deferred Tax Liability changed N/A to $106000.0 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $106000.0 through Dec 2019, changed N/A year-over-year, with the annual reading at $106000.0 for FY2019, N/A changed from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2019 was $106000.0 at Marker Therapeutics.
  • The five-year high for Non-Current Deferred Tax Liability was $106000.0 in Q4 2019, with the low at $106000.0 in Q4 2019.